Basal Ganglia and Limbic Striatal Regions are Differentially Affected by Pramipexole: D3 receptor – Mediated Changes in Markers of Synaptic Strength
Objective: To determine whether pramipexole (PPX) differentially upregulates AMPA receptor trafficking in limbic vs. motor striatal regions of rats. Background: Impulse control disorders (ICD) are…Is there a significant relationship between weight loss and prevalence of side effects of Parkinsonian medication? A retrospective, single-centre analysis, South Wales, UK.
Objective: To investigate if there is a significant relationship between weight loss in persons with Parkinson’s disease and side-effect incidence, and if so to what…The association between motor laterality and cognitive impairment in Parkinson’s disease
Objective: Our study aimed to compare the cognitive function depending on the one-sided symptom dominance for investigating association between specific cognitive function and asymmetric motor…Multimodal biomarkers as predictors of cognitive decline in Parkinson’s Disease
Objective: To identify a set of multimodal biomarkers to predict cognitive decline in non-demented Parkinson’s disease patients. Background: People with Parkinson’s Disease are at high…Implicit memory analysis in patients with Parkinson’s Disease with Deep Brain Stimulation, in ON and OFF stages, using a computerized test battery.
Objective: This study aims to analyze the DBS effects on the PD patients implicit learning. Background: PD is considered the second more common neurodegenerative disease and initially,…Motor imagery increases imitation of hand movements in Parkinson’s disease
Objective: This study investigated the effects of action observation and motor imagery on movement amplitude in people with Parkinson's disease. Background: Action observation (AO) influences…Effects of education level on motor and non-motor symptoms of Brazilian patients with Parkinson’s disease.
Objective: To investigate the influence of education level (EL) on motor and non-motor aspects of Parkinson’s disease (PD) in a Brazilian sample. Background: Only 30%…Association of Single Nucleotide Polymorphism in MAOB and Risk of Levodopa-Induced Dyskinesias in Parkinson’s Disease
Objective: To identify genetic risk factors for developing levodopa-induced dyskinesias (LID) in patients with Parkinson’s disease (PD). Background: LID are common complications in PD, but…Parkin (PARK 2) Mutations in Patients with Early-Onset Parkinson’s Disease
Objective: Genetic testing Parkin (PARK 2) gene in patients with young-onset Parkinson's disease in Belarus. Background: The diagnosis of young-onset Parkinson's disease (PD) is the same…Genetic variants influencing dyskinesia; potential consequences for treatment in Parkinson’s disease
Objective: To examine the association between dyskinesia and haplotypes in the genes of three dopamine receptors (DRD1, DRD2 and DRD3) and of the Brain Derived…
- « Previous Page
- 1
- …
- 121
- 122
- 123
- 124
- 125
- …
- 155
- Next Page »